Minapharm is leading the health-care industry in Egypt toward biotechnology and advanced therapy medicinal products.

netically engineered products and next-generation advanced therapy medicinal products (ATMPs).

While the focus in Egypt is still on small molecules, Minapharm...

Endorsed by its favourable logistical positioning, cost-efficient production scheme and advantageous trade agreements, Egypt is considered a key pharmaceutical hub for the Middle East, Europe and Africa...

As a prominent base for the manufacture of both new and generic pharmaceuticals, Egypt is an easy stepping stone from which to enter the fast-growing African market. At the forefront of this revolution is Minapharm, with one of the broadest high-quality product portfolios in the industry...

كرمت الدكتورة سحر نصر وزير الإستثمار والتعاون الدولي نيابة عن رئيس مجلس الوزراء المهندس شريف إسماعيل شركة مينافارم للأدوية كواحدة من أفضل الشركات العاملة في مصر لعام 7201، وذلك وفقاً للإستطلاع الذى أجرته مؤسسة “أموال الغد” الإقتصادية المتخصصة بالتعاون مع مجموعة من بنوك الإستثمار لتصنيف أفضل 100 شركة أداء في السوق المصرية...

With 50 years’ experience and regional leadership in the pharmaceutical industry, MINAPHARM is constantly striving to provide innovative quality medicines and services to patients in developing countries...

Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East...

Since most domestic pharma companies and the national drug authorities are preoccupied with today’s pharma challenges (pricing, competition, etc.), limited attention has been given to developing strategies to accommodate growing demand for biologics...

Despite political unrest over the last five years, the pharma sector has witnessed significant growth, driven by the large population and high demand. Consumption of innovative pharmaceuticals and complex recombinant or genetically engineered products, however, is incompatible with demand...